1. Effect of trifluoperazine on in vitro ATP synthesis byMycobacterium leprae
- Author
-
Ravendra K. Sharma, Vishwas Sharma, Saxena N, Channappa T. Shivannavar, V. M. Katoch, Kiran Katoch, and P. Suryanarayana Murthy
- Subjects
Microbiology (medical) ,Immunology ,Trifluoperazine ,Microbiology ,chemistry.chemical_compound ,Adenosine Triphosphate ,Calmodulin ,Biosynthesis ,medicine ,Humans ,Immunology and Allergy ,Mycobacterium leprae ,Incubation ,Antibacterial agent ,biology ,ATP synthase ,Biological activity ,General Medicine ,biology.organism_classification ,In vitro ,Leprosy, Lepromatous ,Infectious Diseases ,chemistry ,biology.protein ,medicine.drug - Abstract
The effect of trifluoperazine (TFP), a calmodulin antagonist, was investigated on in vitro ATP levels of human derived Mycobacterium leprae. M. leprae were obtained from biopsies from multi-bacillary forms of leprosy and were incubated in a modified Dubos medium system which supports limited in vitro synthesis of M. leprae. This incubation was carried out in the absence and presence of different concentrations of trifluoperazine. Samples for estimation of bacillary ATP levels were taken at day 0 and at 14 days of incubation. TFP inhibited ATP levels in M. leprae and this inhibitory effect was marginal at 2.5 Wg ml 31 (35% inhibition), highly significant at 5 W gm l 31 (87% inhibition) and almost total at 10 W gm l 31 (98.5% inhibition). This compound appears to have potential as an anti-leprotic drug and also as a broad spectrum anti-mycobacterial agent in view of its anti-tubercular activity reported earlier. z 1998 Federation of European Microbiological Societies. Published by Elsevier Science B.V.
- Published
- 1998
- Full Text
- View/download PDF